medigraphic.com
ISSN 1561-3100 (Print)

2020, Number 1

<< Back Next >>

Revista Cubana de Ortopedia y Traumatología 2020; 34 (1)

What an orthopedic surgeon should know of osteoporosis and bone fragility fractures

Fantin EA

Language: Spanish
References: 14
Page: 1-23
PDF size: 597.44 Kb.


ABSTRACT

Introduction: Osteoporosis is the most common bone disease in aged adults and it constitutes a major public health problem throughout the world.
Objective: To update concepts on osteoporosis and treatment.
Methods: A review of publications from 2010 to 2020 in English was carried out, using the terms “osteoporosis”, “treatment of osteoporosis”, “osteoporosis fractures”.
Results: Osteoporosis has great impact not only clinically, but economically and socially as well. Its treatment includes general measures and the use of various groups of drugs. The possibility of fragility fractures in the wrist, spine and hip is significant, which determines high morbidity and mortality.


REFERENCES

  1. Johnell O, Kanis J. Epidemiology of osteoporotic fractures. Osteoporos Int. 2005 Mar;16 Suppl 2:S3-7.

  2. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2007;22(3):465-75.

  3. Johnell O. The socioeconomic burden of fractures: today and in the 21st century. Am J Med. 1997;103(2a):20S-5S. DOI: 10.1016/s0002-9343(97)90023-1

  4. Magaziner J, Hawkes W, Hebel JR, Zimmerman SI, Fox KM, Dolan M, et al. Recovery from hip fracture in eight areas of function. J Gerontol A Biol Sci Med Sci. 2000;55(9):M498-507.

  5. Papaioannou A, Santesso N, Morin SN. Recommendations for preventing fracture in long-term care. CMAJ. 2015;187(15):1135-44.

  6. Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007;357(18):1799-809.

  7. Xue D, Li F, Chen G, Yan S, Pan Z. Do bisphosphonates affect bone healing? A meta-analysis of randomized controlled trials. J Orthop Surg Res. 2014:9-45.

  8. Li YT, Cai HF, Zhang ZL. Timing of the initiation of bisphosphonates after surgery for fracture healing: a systematic review and meta-analysis of randomized controlled trials. Osteoporos Int. 2015;26(2):431-41.

  9. Cosman F, de Beur SJ, LeBoff MS. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014;25(10):2359-81.

  10. Siddiqui NA, Shetty KR, Duthie EH Jr. Osteoporosis in older men: discovering when and how to treat it. Geriatrics. 1999;54(9):20-2;27-8;30.

  11. Kanis JA. Fracture Risk Assessment Tool (FRAX). Centre for Metabolic Bone Diseases. University of Sheffield, UK. [Acceso: 2016]. Disponible en: https://www.sheffield.ac.uk/FRAX/

  12. Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol. 2005;23(34):8580-7.

  13. Schilcher J, Koeppen V, Aspenberg P, Michaëlssonet K. Risk of atypical femoral fracture during and after bisphosphonate use. Acta Orthop. 2015;86(1):100-7.

  14. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich JA, Reginster JY, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001; 344(19):1434-41.




2020     |     www.medigraphic.com